Skip to content

Clinical trials

Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Country / region: Sweden Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20091
20173
20181
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Birgitte Klug Albertsen1
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
Janssen Research & Development, LLC1
Lund University Hospital1
Pfizer1
Rigshospitalet, Denmark1
Sanofi1
Vastra Gotaland Region1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Leukemia2
Leukemia, Myeloid, Acute2
Graft vs Host Disease1
Hematologic Neoplasms1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.